Prospects for Illumina Inc. (Nasdaq: ILMN) brightened after the genetic test maker posted fourth quarter profits that climbed to 22 cents per share from a loss of 4 cents per share a year earlier to beat expectations. Analysts promptly upgraded the stock sending the stock price soaring $5.61 to $33.60.
Illumina Beats Estimates
February 04, 2009 at 12:09 PM EST
